SEARCH

SEARCH BY CITATION

References

  • 1
    Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd. Factors of risk in the development of coronary heart disease–six year follow-up experience. The Framingham Study. Ann Intern Med 1961; 55: 33-50.
  • 2
    Gill T, Chittleborough C, Taylor A et al. Body mass index, waist hip ratio, and waist circumference: which measure to classify obesity? Soz Praventivmed 2003; 48: 191-200.
  • 3
    Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2010; 375: 181-183.
  • 4
    Simmons RK, Alberti KG, Gale EA et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010; 53: 600-605.
  • 5
    Whitlock G, Lewington S, Sherliker P et al.; Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-1096.
  • 6
    Mathieu P, Poirier P, Pibarot P, Lemieux I, Després JP. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 2009; 53: 577-584.
  • 7
    Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 2004; 89: 2601-2607.
  • 8
    Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697-738.
  • 9
    Pischon T, Boeing H, Hoffmann K et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105-2120.
  • 10
    Yusuf S, Hawken S, Ounpuu S et al.; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649.
  • 11
    Lee CM, Huxley RR, Wildman RP, Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol 2008; 61: 646-653.
  • 12
    Gelber RP, Gaziano JM, Orav EJ et al. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol 2008; 52: 605-615.
  • 13
    Schneider HJ, Glaesmer H, Klotsche J et al.; DETECT Study Group. Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab 2007; 92: 589-594.
  • 14
    Bergman RN, Stefanovski D, Buchanan TA et al. A better index of body adiposity. Obesity (Silver Spring) 2011; 19: 1083-1089.
  • 15
    Kiefer I, Kunze U, Mitsche N, Kunze M. [Obesity in Austria: epidemiologic and social medicine aspects]. Acta Med Austriaca 1998; 25: 126-128.
  • 16
    Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr 1991; 65: 105-114.
  • 17
    Steiger JH. Tests for comparing elements of a correlation matrix. Psychol Bull 1980; 87: 245-251.
  • 18
    Borenstein MHL, Higgins J, Rothstein H. Introduction to Meta-Analysis. John Wiley & Sons, 2009.
  • 19
    DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
  • 20
    Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008; 117: 1658-1667.
  • 21
    Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 2006; 35: 83-92.
  • 22
    Cancello R, Tordjman J, Poitou C et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006; 55: 1554-1561.
  • 23
    Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56: 1010-1013.
  • 24
    Dusserre E, Moulin P, Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 2000; 1500: 88-96.
  • 25
    Yang R, Barouch LA. Leptin signaling and obesity: cardiovascular consequences. Circ Res 2007; 101: 545-559.
  • 26
    Patel SB, Reams GP, Spear RM, Freeman RH, Villarreal D. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease. Curr Hypertens Rep 2008; 10: 131-137.
  • 27
    Schram K, Sweeney G. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure. Trends Cardiovasc Med 2008; 18: 199-205.
  • 28
    Lam QL, Lu L. Role of leptin in immunity. Cell Mol Immunol 2007; 4: 1-13.
  • 29
    Schulze PC, Kratzsch J. Leptin as a new diagnostic tool in chronic heart failure. Clin Chim Acta 2005; 362: 1-11.
  • 30
    Lieb W, Sullivan LM, Harris TB et al. Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals. Diabetes Care 2009; 32: 612-616.
  • 31
    Spies C, Farzaneh-Far R, Na B et al. Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study). Am J Cardiol 2009; 104: 883-889.
  • 32
    Rexrode KM, Carey VJ, Hennekens CH et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998; 280: 1843-1848.
  • 33
    Meigs JB, Wilson PW, Fox CS et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906-2912.
  • 34
    McLaughlin T, Abbasi F, Lamendola C, Reaven G. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med 2007; 167: 642-648.
  • 35
    Lempiäinen P, Mykkänen L, Pyörälä K, Laakso M, Kuusisto J. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 1999; 100: 123-128.
  • 36
    Jeppesen J, Hansen TW, Rasmussen S et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol 2007; 49: 2112-2119.
  • 37
    Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 2008; 94: 206-218.
  • 38
    Weerarathna TP, Lekamwasam S, Rodrigo M. Prediction of total and visceral fat contents using anthropometric measures of adiposity in women. Ceylon Med J 2008; 53: 128-132.
  • 39
    See R, Abdullah SM, McGuire DK et al. The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study. J Am Coll Cardiol 2007; 50: 752-759.
  • 40
    Canoy D. Distribution of body fat and risk of coronary heart disease in men and women. Curr Opin Cardiol 2008; 23: 591-598.